X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (254) 254
life sciences & biomedicine (252) 252
oncology (233) 233
humans (211) 211
female (199) 199
breast cancer (175) 175
breast neoplasms - drug therapy (142) 142
middle aged (133) 133
adult (116) 116
breast neoplasms - pathology (109) 109
cancer (101) 101
aged (98) 98
antineoplastic combined chemotherapy protocols - therapeutic use (94) 94
chemotherapy (84) 84
treatment outcome (84) 84
neoadjuvant therapy (80) 80
chemotherapy, adjuvant (60) 60
care and treatment (55) 55
disease-free survival (55) 55
prognosis (55) 55
breast neoplasms - mortality (52) 52
obstetrics & gynecology (51) 51
neoplasm staging (49) 49
adjuvant treatment (48) 48
medicine & public health (47) 47
breast neoplasms - surgery (45) 45
clinical trials (41) 41
research (40) 40
trastuzumab (40) 40
health aspects (38) 38
hematology, oncology and palliative medicine (38) 38
taxoids - administration & dosage (36) 36
cyclophosphamide - administration & dosage (35) 35
prospective studies (35) 35
breast neoplasms - metabolism (34) 34
analysis (33) 33
antineoplastic combined chemotherapy protocols - adverse effects (33) 33
drug therapy (32) 32
drug administration schedule (31) 31
breast neoplasms - therapy (30) 30
further section · weitere sektionen (30) 30
antineoplastic agents - therapeutic use (29) 29
metastasis (28) 28
tumors (28) 28
further section (27) 27
antineoplastic combined chemotherapy protocols - administration & dosage (26) 26
cancer therapies (26) 26
receptor, erbb-2 - metabolism (26) 26
germany (25) 25
oncology, experimental (25) 25
anthracyclines (24) 24
paclitaxel - administration & dosage (24) 24
surgery (24) 24
young adult (24) 24
epirubicin - administration & dosage (23) 23
abridged index medicus (22) 22
neoadjuvant chemotherapy (22) 22
patients (22) 22
risk factors (22) 22
doxorubicin - administration & dosage (21) 21
randomized controlled trials as topic (21) 21
survival analysis (21) 21
aged, 80 and over (20) 20
erbb-2 protein (20) 20
cancer patients (19) 19
follow-up studies (19) 19
neoadjuvant therapy - methods (19) 19
survival rate (19) 19
breast neoplasms - chemistry (17) 17
fluorouracil - administration & dosage (17) 17
immunohistochemistry (17) 17
receptor, erbb-2 - analysis (17) 17
time factors (17) 17
antibodies, monoclonal, humanized - administration & dosage (16) 16
antimitotic agents (16) 16
antineoplastic agents (16) 16
biomarkers, tumor - analysis (16) 16
breast neoplasms - diagnosis (16) 16
capecitabine (16) 16
dose-response relationship, drug (16) 16
lymphatic metastasis (16) 16
survival (16) 16
biomarkers (15) 15
breast neoplasms - genetics (15) 15
deoxycytidine - administration & dosage (15) 15
deoxycytidine - analogs & derivatives (15) 15
pathological complete response (15) 15
research article (15) 15
clinical trials as topic (14) 14
epidermal growth factor (14) 14
fluorouracil - analogs & derivatives (14) 14
general & internal medicine (14) 14
kaplan-meier estimate (14) 14
medicine, general & internal (14) 14
metastatic breast cancer (14) 14
neoadjuvant (14) 14
paclitaxel (14) 14
proportional hazards models (14) 14
surgical oncology (14) 14
antineoplastic agents, hormonal - therapeutic use (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Im Focus Onkologie, ISSN 1435-7402, 11/2012, Volume 15, Issue 11, pp. 95 - 95
Journal Article
The Lancet (British edition), ISSN 0140-6736, 07/2014, Volume 384, Issue 9938, pp. 164 - 172
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2012, Volume 366, Issue 17, pp. 1638 - 1639
Journal Article
Journal Article
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2017, Volume 377, Issue 2, pp. 122 - 131
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 05/2012, Volume 30, Issue 15, pp. 1796 - 1804
Journal Article